Results 241 to 250 of about 52,263 (284)
Some of the next articles are maybe not open access.

Stereotactic Body Radiotherapy

Clinical Oncology, 2015
Stereotactic body radiotherapy (SBRT), which is also referred to as stereotactic ablative radiotherapy (SABR) and extra-cranial stereotactic radiosurgery, has been rapidly diffusing into clinical practice [1,2]. Over the last few years it has become established as an out-patient, nonor minimally invasive treatment option for certain clinical ...
Dahele, M.R., McLaren, D.B.
openaire   +4 more sources

Stereotactic Body Radiotherapy

Seminars in Oncology, 2014
Extracranial stereotactic body radiotherapy (SBRT) has been developed and refined over the last 25 years as a means to precisely deliver ablative doses of hypofractionated radiotherapy to small targets located outside of the cranial vault. SBRT has armed the radiation oncologist with a therapeutic approach that allows for intensification of both dose ...
Laura, Kollar, Ramesh, Rengan
openaire   +2 more sources

Stereotactic body radiotherapy

BMJ, 2011
Early results show promise, but training and long term research are needed before wider ...
openaire   +2 more sources

Stereotactic Radiotherapy for Pulmonary Metastases

Seminars in Thoracic and Cardiovascular Surgery, 2013
The most common treatment of pulmonary metastasis for solid tumors employs systemic chemotherapy, hormonal therapy, or biologic agents. Some series have suggested that aggressive surgical resection of pulmonary metastasis may improve patient outcomes in terms of quality of life and overall survival. Recently, data from clinical trials and retrospective
Steven J, Chmura   +2 more
openaire   +2 more sources

Multi-fractionated stereotactic radiotherapy

Medical Dosimetry, 1996
Precision and accuracy of a patient's treatment are key advantages of single-fraction stereotactic radiosurgery (SRS) for arteriovenous malformations (AVMS) and some small brain metastases. These advantages are equally valuable in fractionated treatment of the pituitary, brain metastases and brain boost fields.
T L, Edlund, J H, Moeller, D D, Leavitt
openaire   +2 more sources

Stereotactic ablative radiotherapy: what's in a name?

Practical Radiation Oncology, 2011
Department of Radiation Oncology, Stanford University and Cancer Center, Stanford, California Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas Department of Radiation Oncology, University of Toronto/Princess Margaret Hospital, Toronto, Ontario, Canada Department of Radiation Oncology, University of ...
Loo, Billy W.   +6 more
openaire   +2 more sources

Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy for Arteriovenous Malformation

World Neurosurgery, 2023
The best management for AVM, particularly high-grade ones and those that have been ruptured before, is still unknown. Data from prospective data lacks support for the best approach.We retrospectively review patients with AVM at a single institution that were treated with radiation or a combination of radiation and embolization.
Leila Maria Da Róz   +6 more
openaire   +2 more sources

Stereotactic radiotherapy

2018
This case study looks at Stereotactic radiotherapy, and provides questions with model answers.
Kobika Sritharan, Julian Singer
openaire   +1 more source

[Stereotactic radiotherapy in brain metastases].

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2015
Stereotactic radiotherapy of brain metastases is increasingly proposed after polydisciplinary debates among experts. Its definition and modalities of prescription, indications and clinical interest regarding the balance between efficacy versus toxicity need to be discussed.
Dhermain, Frédéric   +5 more
openaire   +2 more sources

The History of Stereotactic Radiosurgery and Radiotherapy

Otolaryngologic Clinics of North America, 2009
Stereotactic neurosurgery originated from the pioneering work of Horsley and Clarke, who developed a stereotactic apparatus to study the monkey brain in 1908. Spiegel and Wycis applied this technology to the human brain in 1947, which ultimately lead to the development of multiple stereotactic neurosurgical devices during the 1950s. It was Lars Leksell
John M, Lasak, John P, Gorecki
openaire   +2 more sources

Home - About - Disclaimer - Privacy